Compare Cannabis Stocks

Compare Cannabis stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., CGC, JAZZ, ABBV, HEXO) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CGC Canopy Growth	$0.93 +1.1%	$1.47	$0.83 ▼ $14.92	$147.59M	0.92	6.88 million shs	2.57 million shs
JAZZ Jazz Pharmaceuticals	$106.93 -2.8%	$131.92	$99.06 ▼ $148.06	$6.49B	0.42	756,011 shs	1.63 million shs
ABBV AbbVie	$186.11 -0.5%	$200.79	$153.58 ▼ $218.66	$329.22B	0.55	5.78 million shs	12.58 million shs
HEXO HEXO	$0.71 +2.5%	$0.87	$0.66 ▼ $3.84	$31.24M	1.35	880,508 shs	305,500 shs
MO Altria Group	$55.72 -0.6%	$55.77	$40.65 ▼ $60.18	$94.21B	0.54	8.94 million shs	16.83 million shs
SMG Scotts Miracle-Gro	$52.52 +2.2%	$61.96	$49.39 ▼ $93.90	$3.02B	1.96	859,356 shs	2.24 million shs
CURLF Curaleaf	$0.74 -4.2%	$1.18	$0.68 ▼ $6.40	$488.09M	0.95	704,313 shs	674,651 shs
GTBIF Green Thumb Industries	$5.06 +0.8%	$6.58	$4.63 ▼ $16.33	$1.07B	1.35	491,283 shs	745,607 shs
TCNNF Trulieve Cannabis	$3.30 +2.2%	$4.27	$3.02 ▼ $14.50	N/A	N/A	496,319 shs	559,008 shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CGC Canopy Growth	+1.14%	+2.25%	-20.47%	-67.58%	-90.86%
JAZZ Jazz Pharmaceuticals	-2.83%	-13.87%	-22.97%	-12.74%	-8.15%
ABBV AbbVie	-0.25%	-11.31%	-13.25%	+3.63%	+9.48%
HEXO HEXO	0.00%	0.00%	0.00%	0.00%	0.00%
MO Altria Group	-0.59%	-7.29%	-3.57%	+8.28%	+33.79%
SMG Scotts Miracle-Gro	+2.27%	-4.37%	-15.60%	-21.66%	-29.93%
CURLF Curaleaf	-4.23%	-19.00%	-26.86%	-54.40%	-85.82%
GTBIF Green Thumb Industries	+0.80%	-12.91%	-28.13%	-37.22%	-61.52%
TCNNF Trulieve Cannabis	+2.17%	-14.73%	-22.17%	-37.14%	-73.81%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CGC Canopy Growth	1.9777 of 5 stars	2.5	2.0	0.0	0.0	2.3	0.0	1.3
JAZZ Jazz Pharmaceuticals	4.8023 of 5 stars	4.5	1.0	0.0	4.0	3.5	2.5	3.1
ABBV AbbVie	4.6813 of 5 stars	3.5	3.0	3.3	3.9	3.4	2.5	1.3
HEXO HEXO	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MO Altria Group	2.8719 of 5 stars	1.0	2.0	5.0	0.0	3.3	0.8	1.9
SMG Scotts Miracle-Gro	4.7147 of 5 stars	4.4	1.0	2.5	1.5	3.1	4.2	1.9
CURLF Curaleaf	2.0334 of 5 stars	3.5	3.0	0.0	0.0	1.8	0.0	1.3
GTBIF Green Thumb Industries	2.6891 of 5 stars	3.8	3.0	0.0	0.0	1.1	0.8	1.9
TCNNF Trulieve Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CGC Canopy Growth	1.00	Sell	$2.00	114.94% Upside
JAZZ Jazz Pharmaceuticals	2.93	Moderate Buy	$187.71	75.55% Upside
ABBV AbbVie	2.92	Moderate Buy	$211.45	13.62% Upside
HEXO HEXO	0.00	N/A	N/A	N/A
MO Altria Group	2.00	Hold	$54.00	-3.09% Downside
SMG Scotts Miracle-Gro	2.83	Moderate Buy	$71.83	36.78% Upside
CURLF Curaleaf	3.00	Buy	$6.25	746.08% Upside
GTBIF Green Thumb Industries	3.60	Strong Buy	$16.50	226.09% Upside
TCNNF Trulieve Cannabis	3.00	Buy	$16.75	407.58% Upside

Current Analyst Ratings Breakdown

Latest Cannabis Stocks Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/7/2025	SMG Scotts Miracle-Gro	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$72.00 ➝ $69.00
4/2/2025	SMG Scotts Miracle-Gro	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$80.00 ➝ $70.00
4/2/2025	SMG Scotts Miracle-Gro	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$70.00 ➝ $70.00
4/1/2025	MO Altria Group	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$60.00
4/1/2025	MO Altria Group	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
4/1/2025	MO Altria Group	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sell ➝ Sell	$42.00 ➝ $46.00
3/17/2025	ABBV AbbVie	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/10/2025	JAZZ Jazz Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$200.00 ➝ $217.00
3/7/2025	JAZZ Jazz Pharmaceuticals	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight	$175.00 ➝ $183.00
3/7/2025	JAZZ Jazz Pharmaceuticals	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$145.00 ➝ $179.00
3/6/2025	JAZZ Jazz Pharmaceuticals	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$220.00 ➝ $230.00

(Data available from 4/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CGC Canopy Growth	$276.75M	0.53	N/A	N/A	$2.72 per share	0.34
JAZZ Jazz Pharmaceuticals	$4.07B	1.60	$21.78 per share	4.91	$59.36 per share	1.80
ABBV AbbVie	$56.33B	5.84	$13.76 per share	13.53	$1.90 per share	97.95
HEXO HEXO	$146.20M	0.21	N/A	N/A	$2.44 per share	0.29
MO Altria Group	$20.44B	4.61	$5.42 per share	10.28	($1.29) per share	-43.20
SMG Scotts Miracle-Gro	$3.56B	0.85	$3.12 per share	16.81	($8.34) per share	-6.30
CURLF Curaleaf	$1.35B	0.36	$0.08 per share	9.57	$1.64 per share	0.45
GTBIF Green Thumb Industries	$1.05B	1.02	$0.29 per share	17.27	$8.10 per share	0.62
TCNNF Trulieve Cannabis	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CGC Canopy Growth	-$487.23M	-$3.80	N/A	N/A	N/A	-156.98%	-56.52%	-24.18%	5/29/2025 (Estimated)
JAZZ Jazz Pharmaceuticals	$414.83M	$8.79	15.06	5.72	1.04	11.60%	29.30%	9.72%	4/29/2025 (Estimated)
ABBV AbbVie	$4.28B	$2.40	77.55	13.31	1.62	7.59%	296.28%	12.65%	4/25/2025 (Estimated)
HEXO HEXO	-$845.90M	-$5.21	N/A	N/A	N/A	-235.33%	-74.04%	-32.51%	N/A
MO Altria Group	$11.26B	$6.55	8.51	10.06	2.89	46.90%	-258.72%	25.16%	4/29/2025 (Estimated)
SMG Scotts Miracle-Gro	-$34.90M	-$0.48	N/A	13.00	N/A	-0.67%	-51.48%	4.85%	4/30/2025 (Estimated)
CURLF Curaleaf	-$281.20M	-$0.30	N/A	N/A	N/A	-14.82%	-13.67%	-4.58%	N/A
GTBIF Green Thumb Industries	$36.27M	$0.30	21.08	14.06	N/A	5.38%	3.39%	2.32%	5/7/2025 (Estimated)
TCNNF Trulieve Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	5/7/2025 (Estimated)

Latest Cannabis Stocks Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/30/2025	N/A	SMG Scotts Miracle-Gro	$3.95	N/A	N/A	N/A	$1.50 billion	N/A
4/29/2025	N/A	MO Altria Group	$1.19	N/A	N/A	N/A	$4.64 billion	N/A
4/25/2025	N/A	ABBV AbbVie	$2.51	N/A	N/A	N/A	$12.91 billion	N/A
3/3/2025	Q4 2024	CURLF Curaleaf	-$0.07	$0.02	+$0.09	-$0.10	$331.87 million	$331.05 million
2/26/2025	Q4 2024	GTBIF Green Thumb Industries	$0.06	$0.04	-$0.02	$0.04	$289.66 million	$294.32 million
1/31/2025	Q4 24	ABBV AbbVie	$2.98	$2.16	-$0.82	-$0.02	$14.81 billion	N/A
1/30/2025	Q4 2024	MO Altria Group	$1.28	$1.29	+$0.01	$1.79	$5.04 billion	N/A
1/29/2025	Q1 2025	SMG Scotts Miracle-Gro	-$1.23	-$0.89	+$0.34	-$1.21	$392.62 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CGC Canopy Growth	N/A	N/A	N/A	N/A	N/A
JAZZ Jazz Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
ABBV AbbVie	$6.56	3.52%	+6.04%	273.33%	53 Years
HEXO HEXO	N/A	N/A	N/A	N/A	N/A
MO Altria Group	$4.08	7.32%	+4.35%	62.29%	56 Years
SMG Scotts Miracle-Gro	$2.64	5.03%	+1.03%	N/A	N/A
CURLF Curaleaf	N/A	N/A	N/A	N/A	N/A
GTBIF Green Thumb Industries	N/A	N/A	N/A	N/A	N/A
TCNNF Trulieve Cannabis	N/A	N/A	N/A	N/A	N/A

Latest Cannabis Stocks Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/13/2025	ABBV AbbVie	quarterly	$1.64	3.4%	4/15/2025	4/15/2025	5/15/2025
2/27/2025	MO Altria Group	quarterly	$1.02	7.4%	3/25/2025	3/25/2025	4/30/2025
1/27/2025	SMG Scotts Miracle-Gro	quarterly	$0.66	3.4%	2/21/2025	2/21/2025	3/7/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CGC Canopy Growth	0.74	3.52	2.58
JAZZ Jazz Pharmaceuticals	1.46	4.26	3.74
ABBV AbbVie	17.94	0.66	0.55
HEXO HEXO	0.01	0.41	0.24
MO Altria Group	N/A	0.51	0.39
SMG Scotts Miracle-Gro	N/A	1.88	0.55
CURLF Curaleaf	0.85	1.11	0.51
GTBIF Green Thumb Industries	N/A	2.40	1.72
TCNNF Trulieve Cannabis	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CGC Canopy Growth	3.33%
JAZZ Jazz Pharmaceuticals	89.14%
ABBV AbbVie	70.23%
HEXO HEXO	7.78%
MO Altria Group	57.41%
SMG Scotts Miracle-Gro	74.07%
CURLF Curaleaf	0.03%
GTBIF Green Thumb Industries	0.09%
TCNNF Trulieve Cannabis	N/A

Insider Ownership

Company	Insider Ownership
CGC Canopy Growth	1.30%
JAZZ Jazz Pharmaceuticals	4.20%
ABBV AbbVie	0.25%
HEXO HEXO	4.69%
MO Altria Group	0.09%
SMG Scotts Miracle-Gro	25.37%
CURLF Curaleaf	N/A
GTBIF Green Thumb Industries	10.40%
TCNNF Trulieve Cannabis	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CGC Canopy Growth	3,150	158.61 million	153.39 million	Optionable
JAZZ Jazz Pharmaceuticals	3,200	60.73 million	57.92 million	Optionable
ABBV AbbVie	50,000	1.77 billion	1.76 billion	Optionable
HEXO HEXO	1,277	44.00 million	41.93 million	Optionable
MO Altria Group	6,300	1.69 billion	1.69 billion	Optionable
SMG Scotts Miracle-Gro	6,200	57.47 million	42.89 million	Optionable
CURLF Curaleaf	5,600	660.74 million	N/A	Not Optionable
GTBIF Green Thumb Industries	3,800	212.29 million	187.51 million	Not Optionable
TCNNF Trulieve Cannabis	9,000	N/A	N/A	Not Optionable

Cannabis Stocks Headlines

Recent News About These Companies

This Is How Will Marijuana Stocks May Be Impacted By Donald Trump's Tariffs

April 7 at 10:01 AM | marijuanastocks.com

Starting The Week With Top Marijuana Stocks To Watch Today

March 31, 2025 | marijuanastocks.com

Cannabis facility in Jefferson County sparks odor complaints and property value concerns

March 28, 2025 | wtxl.com

Cannabis Stocks Surge After Gaetz Says Trump Backs Federal Rescheduling

March 28, 2025 | markets.businessinsider.com

Trulieve Expands Distribution of Onward THC Beverages in Florida

March 26, 2025 | tipranks.com

Trulieve Announces Expanded Distribution of Premium THC Beverage Onward

March 26, 2025 | prnewswire.com

Trulieve Expands with New Dispensary in North Miami Beach

March 18, 2025 | tipranks.com

3 Top Marijuana For Better Trading After Earnings

March 17, 2025 | marijuanastocks.com

California cannabis chain alleges Trulieve stole $305k through tax refund scheme

March 12, 2025 | greenmarketreport.com

3 Marijuana Stocks To Watch This Month As Trading May Begin To Build

March 10, 2025 | marijuanastocks.com

Trulieve Cannabis Sees Another CFO Resign

March 7, 2025 | thedeepdive.ca

3 Marijuana Stocks To Keep On Your Radar 2025

March 7, 2025 | marijuanastocks.com

Trulieve Announces Appointment of Ryan Blust as Interim Chief Financial Officer

March 7, 2025 | prnewswire.com

Seaport Global Keeps Their Buy Rating on Trulieve Cannabis (TCNNF)

March 6, 2025 | markets.businessinsider.com

Trulieve Cannabis price target lowered to $21 from $24 at Seaport Research

March 6, 2025 | markets.businessinsider.com

Investing in Cannabis: Best U.S. Marijuana Stocks to Track in March 2025

March 2, 2025 | marijuanastocks.com

Haywood Sticks to Their Buy Rating for Trulieve Cannabis (TCNNF)

February 28, 2025 | markets.businessinsider.com

Trulieve Q4 Revenue Lifts as Adjusted EBITDA Soars

February 28, 2025 | newcannabisventures.com

Trulieve Q4 Revenue Lifts as Adjusted EBITDA Soars

February 28, 2025 | newcannabisventures.com

Trulieve beats fourth-quarter revenue estimates, sees strong margins

February 28, 2025 | greenmarketreport.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
By Thomas Hughes | March 12, 2025
View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
3 Defense Stocks Set to Benefit From Increased Military Spending
By Chris Markoch | March 20, 2025
View 3 Defense Stocks Set to Benefit From Increased Military Spending
AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
By Chris Markoch | March 23, 2025
View AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
These Dividend Stocks Might Be the Safest Bet Right Now
By Gabriel Osorio-Mazilli | April 7, 2025
View These Dividend Stocks Might Be the Safest Bet Right Now

Cannabis Stocks Company Descriptions

Canopy Growth NASDAQ:CGC

$0.93 +0.01 (+1.14%)

Closing price 04/7/2025 04:00 PM Eastern

Extended Trading

$0.92 -0.01 (-0.59%)

As of 04/7/2025 07:53 PM Eastern

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Jazz Pharmaceuticals NASDAQ:JAZZ

$106.93 -3.11 (-2.83%)

Closing price 04/7/2025 04:00 PM Eastern

Extended Trading

$113.50 +6.57 (+6.14%)

As of 04/7/2025 07:47 PM Eastern

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia; Xyrem to treat cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut and Dravet syndromes, or tuberous sclerosis complex; Zepzelca to treat metastatic small cell lung cancer, or with disease progression on or after platinum-based chemotherapy; Rylaze for acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Defitelio to treat severe hepatic veno-occlusive disease; and Vyxeos for newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Zepzelca for the treatment of patients with select relapsed/refractory solid tumors based on limited response in three solid tumor cohorts; JZP815, a pan-RAF kinase inhibitor that targets components of the mitogen-activated protein kinase; JZP898, a conditionally-activated interferon alpha molecule; Epidiolex to treat LGS, DS, and TSC; Suvecaltamide to treat parkinson's disease tremor; JZP150, a fatty acid amide hydrolase inhibitor program to treat post-traumatic stress disorder; and JZP441 to treat narcolepsy, IH, and other sleep disorders. The company has licensing and collaboration agreements with XL-protein GmbH to extend the plasma half-life of selected asparaginase product candidates; Redx Pharma plc for preclinical activities Ras/Raf/MAP kinase pathway program; and Autifony Therapeutics Limited on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.

AbbVie NYSE:ABBV

$186.11 -0.85 (-0.45%)

Closing price 04/7/2025 03:59 PM Eastern

Extended Trading

$186.74 +0.63 (+0.34%)

As of 04/7/2025 08:00 PM Eastern

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

HEXO NYSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

Altria Group NYSE:MO

$55.72 -0.35 (-0.62%)

Closing price 04/7/2025 03:59 PM Eastern

Extended Trading

$55.91 +0.19 (+0.34%)

As of 04/7/2025 07:59 PM Eastern

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.

Scotts Miracle-Gro NYSE:SMG

$52.52 +1.11 (+2.16%)

Closing price 04/7/2025 03:59 PM Eastern

Extended Trading

$52.08 -0.43 (-0.82%)

As of 04/7/2025 06:30 PM Eastern

The Scotts Miracle-Gro Company, together with its subsidiaries, manufactures, markets, and sells products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. It operates through three segments: U.S. Consumer, Hawthorne, and Other. The company provides lawn care products, comprising lawn fertilizers, grass seed products, spreaders, and other durable products, as well as lawn-related weed, pest, and disease control products; and gardening and landscape products, which include water-soluble and continuous-release plant foods, potting mixes, garden soils, mulches and ground cover products, plant-related pest and disease control products, organic garden products, and live goods and seeding solutions. It offers hydroponic products that help users to grow plants, flowers, and vegetables using little or no soil; lighting systems and components for use in hydroponic and indoor gardening applications; insect, rodent, and weed control products for home areas; and non-selective weed killer products. The company sells its products under the Scotts, Turf Builder, EZ Seed, PatchMaster, Thick'R Lawn, GrubEx, EdgeGuard, Handy Green II, Miracle-Gro, LiquaFeed, Shake N Feed, Hyponex, Earthgro, Nature Scapes, Ortho, Miracle-Gro Performance Organics, Miracle-Gro Organic Choice, Whitney Farms, EcoScraps, Mother Earth, Botanicare, General Hydroponics, Cyco, Gavita, Agrolux, HydroLogic Purification System, Gro Pro, AeroGarden, Titan, Tomcat, Ortho Weed B Gon, Roundup, Groundclear, and Alchemist brands. It serves home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, and food and drug stores, as well as indoor gardening and hydroponic distributors, retailers, and growers. The Scotts Miracle-Gro Company was founded in 1868 and is headquartered in Marysville, Ohio.

Curaleaf OTCMKTS:CURLF

$0.74 -0.03 (-4.23%)

As of 04/7/2025 03:59 PM Eastern

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

Green Thumb Industries OTCMKTS:GTBIF

$5.06 +0.04 (+0.80%)

As of 04/7/2025 03:58 PM Eastern

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

Trulieve Cannabis OTCMKTS:TCNNF

$3.30 +0.07 (+2.17%)

As of 04/7/2025 03:57 PM Eastern

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It also operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Cannabis Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest Cannabis Stocks Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest Cannabis Stocks Earnings

Compare Dividends

Latest Cannabis Stocks Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

Cannabis Stocks Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Cannabis Stocks Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools